Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?

Circulation

Volumn 110, Issue 12, 2004, Pages 1626-1631

  Pouly, Julia ^a,b,c,f   Hagège, Albert A ^b,c,d   Vilquin, Jean Thomas ^a   Bissery, Alvine ^c   Rouche, Andreée ^a   Bruneval, Patrick ^c   Duboc, Denis ^e   Desnos, Michel ^b,c,d   Fiszman, Marc ^a   Fromes, Yves ^a   Menascheé, Philippe ^b,c,d  

^a INSERM   (France)

^b HÔPITAL BROUSSAIS   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Hôpital Cochin ^*  (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiomyopathy; Heart failure; Myoblasts, skeletal; Tissue therapy

Indexed keywords

DESMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL CULTURE; CELL TRANSPLANTATION; CONTROLLED STUDY; EXPLANT; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; IMMUNOHISTOCHEMISTRY; INJECTION; MALE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SYRIAN HAMSTER; TIBIALIS ANTERIOR MUSCLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; CARDIOMYOPATHY, DILATED; CELLS, CULTURED; CRICETINAE; FEMALE; FIBROSIS; HEART VENTRICLES; INJECTIONS; MALE; MESOCRICETUS; MUSCLE, SKELETAL; MYOBLASTS; MYOCARDIUM; RANDOM ALLOCATION; SARCOGLYCANS; SINGLE-BLIND METHOD; TRANSPLANTATION, HETEROTOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 20844462716     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000142861.55862.15     Document Type: Article

References (34)

1. Codd MB, Sugrue DD, Gersch BJ, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-based study in Olmsted Country, Minnesota, 1975-1984. Circulation. 1989;80: 564-572.
2. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:1564-1575.
3. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334: 1349-1355.
4. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation. 2000;102:1076-1078.
5. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for endstage heart failure. N Engl J Med. 2001;345: 1435-1443.
6. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronisation and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
7. Miiller-Ehmsen J, Peterson KL, Kedes L, et al. Long term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 2002;105:1720-1726.
8. Murry CE, Wiseman RW, Schwartz SM, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512-2523.
9. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
10. Ghostine S, Guarita Sousa LC, Carrion C, et al. Skeletal myoblast transplantation decreases fibrosis and improves regional function of infarcted myocardial areas. Circulation. 2002;106(suppl I):I-131-I-136.
11. Pagani F, DerSimonian R, Zawadska A, et al. Autologous skeletal myoblasts transplanted to ischemia damaged myocardium in humans. J Am Coll Cardiol. 2003;41:879-888.
12. Menascheé P, Hagège AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet. 2001;357:279-280.
13. Menascheé Ph, Hagège AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1078-1083.
14. Nigro V, Okazaki Y, Belsito A, et al. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet. 1997;6:601-607.
15. Matsubayashi K, Fedak PWM, Mickle DAG, et al. Improved left ventricular aneurysm repair with bio engineered vascular smooth muscle grafts. Circulation. 2003;108(suppl II):II-219. Abstract.
16. Nomoto T, Nishina T, Miwa S, et al. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation. 2002;106(suppl I):I-115. Abstract.
17. Watson LE, Sheth M, Denyer RF, et al. Baseline echocardiographic values for adult male rats. J Am Soc Echocardiogr. 2004;17:161-167.
18. Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med. 2001;2:208-210.
19. Menascheé P. Skeletal muscle satellite cell transplantation. Cardiovasc Res. 2003:58:351-357.
20. Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation. 2001;103:1920-1927.
21. Minami E, Reinecke H, Murry CE. Skeletal muscle meets cardiac muscle: friends or foes? J Am Coll Cardiol. 2003;41:1084-1086.
22. Hagège AA, Carrion C, Menascheé P, et al. Autologous myoblast grafting in ischemic cardiomyopathy: clinical validation of long-term cell viability and differentiation. Lancet. 2003;361:491-492.
23. Scorsin M, Hagège AA, Dolizy I, et al. Can cellular transplantation improve function in doxorubicin-induced heart failure? Circulation. 1998;98(suppl II):II-151-II-6.
24. Koh GY, Soonpaa MH, Klug MG, et al. Stable fetal cardiomyocyte graft in the hearts of dystrophic mice and dogs. J Clin Invest. 1995;96:2034-2042.
25. Yoo KJ, Li RK, Weisel RD, et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation. 2000;102(suppl III):III-204-III-209.
26. Yoo KJ, Li RK, Weisel RD, et al. Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. Ann Thorac Surg. 2000;70:859-865.
27. Suzuki K, Murtuza B, Suzuki N, et al. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001;104(suppl):I-213-I-217.
28. Straub V, Duclos F, Venzke DP, et al. Molecular pathogenesis of muscle degeneration in the δ-sarcoglycan-deficient hamster. Am J Pathol. 1998;153: 1623-1630.
29. Steinberg JS, Gaur A, Sciacca R, et al. New-onset sustained ventricular tachycardia after cardiac surgery. Circulation. 1999;99:903-908.
30. Reinecke H, McDonald GH, Hauschka SD, et al. Electromechanical coupling between skeletal and cardiac muscle: implications for infarct repair. J Cell Biol. 2000;149:731-740.
31. Leéobon B, Menascheé P, Vilquin JT, et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA. 2003;100:7808-7811.
32. Murtuza B, Suzuki K, Bou-Gharios G, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infracted murine myocardium. Proc Natl Acad Sci USA. 2004;101: 4216-4221.
33. Sperelakis N. An electric field mechanism for transmission of excitation between myocardial cells. Circ Res. 2002;91:985-987.
34. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.